top of page
​At Heinz Ventures, we believe that credibility is earned through contribution, not purchased through advertising or pay-to-play engagements. The stories and resources shared here highlight our active participation in the medtech innovation ecosystem: invited talks, thought-leadership articles, advisory roles, and collaborative initiatives that advance patient-centered technologies. Our mission is to inspire innovation, foster meaningful partnerships, and support founders building solutions that improve lives, all while maintaining the highest standards of integrity and regulatory compliance.

Media & Insights

Podcasts & Webinars

The Future of Neurological Disease Diagnosis and Treatment

Fireside Chat Series - Episode #1 - Ryan Myers, CranioSense

Jun 19, 2025

Eric Heinz - Managing Partner, Heinz Ventures

The Future of Neurological Disease Diagnosis and Treatment

LinkedIn Live Session Discussing MedTech Venture Capital

The Executive Edge - MedTech Venture Capital

May 15, 2025

Joe McClung - President & CCO - FloodGate Medical

LinkedIn Live Session Discussing MedTech Venture Capital

The MedTech Conference powered by AdvaMed

Maximize Your ROI Webinar: 2024 MedTech Conference by AdvaMed

Sep 18, 2024

Beth Perkins - Director Business Development and Investor Relations

The MedTech Conference powered by AdvaMed

In this session, successful fund managers that have gone through the VC Lab program discuss why they invest in healthcare companies and how to go about starting an enduring VC firm.

VC Lab Webinar | Meet the Managers: Healthcare

Jul 3, 2024

Nils De Jonghe, Community Engagement Associate

In this session, successful fund managers that have gone through the VC Lab program discuss why they invest in healthcare companies and how to go about starting an enduring VC firm.

Funding Medtech Podcast - Episode 16 - Eric Heinz, Heinz Ventures

Funding Medtech Podcast - Episode 16

Mar 6, 2024

Rich Mazzola - Project Medtech

Funding Medtech Podcast - Episode 16 - Eric Heinz, Heinz Ventures

Corporate Development

Medtech Money Podcast - Episode 8: Eric Heinz

Jul 28, 2021

Giovanni Lauricella - Mr. Medtech, LifeBlood Capital

Corporate Development

Panels & Events

Judge with several other regional venture capitalists

Olin School of Business at Washington University, St. Louis: Ideas to Impact Pitch Competition

Oct 15, 2025

Patrick Aguilar, MD, MBA, Managing Director of Health at Olin Business School

Judge with several other regional venture capitalists

Esteemed subject matter experts discuss the commercialization of health innovations, including Nir Goldenberg, Director of Technology, Mayo Clinic Ventures, Stephen Boppart, Grainger Distinguished Chair & Professor, Bioengineering / Electrical & Computer Engineering, University of Illinois Urbana-Champaign, and Michelle Hoffmann, Executive Director, Chicago Biomedical Consortium.

Founders Week 2025 @ The University of Illinois, Urbana-Champaign: Commercializing Health Innovations Panel

Oct 10, 2025

Eric Heinz, Founder & CEO, Heinz Ventures

Esteemed subject matter experts discuss the commercialization of health innovations, including Nir Goldenberg, Director of Technology, Mayo Clinic Ventures, Stephen Boppart, Grainger Distinguished Chair & Professor, Bioengineering / Electrical & Computer Engineering, University of Illinois Urbana-Champaign, and Michelle Hoffmann, Executive Director, Chicago Biomedical Consortium.

Perspectives shared by pairs of investors and founders, including Santé Ventures and Catalyst Health Ventures

AdvaMed Medtech Conference - 2025: Finding the Right Match: Early-Stage MedTech Financing From Both Sides of the Table

Oct 6, 2025

Eric Heinz, Founder & Managing Partner, Heinz Ventures

Perspectives shared by pairs of investors and founders, including Santé Ventures and Catalyst Health Ventures

Closing panel - Ask The Investors

MedTech World - San Jose, CA

Jun 27, 2025

Paul Grand, CEO, Medtech Innovator

Closing panel - Ask The Investors

Judge for the MedTech Industry's Leading Accelerator

Medtech Innovator East Coast Pitch Event - University of Maryland

Apr 9, 2025

Paul Grand, CEO, Medtech Innovator

Judge for the MedTech Industry's Leading Accelerator

"Investing Early - Has the Bar Moved in Early Stage-VC, and How Should CEOs React?"

LSI 2025 Panel - Dana Point, CA

Mar 17, 2025

Amy Salzhauer, Founder and Managing Partner, Good Growth Capital

"Investing Early - Has the Bar Moved in Early Stage-VC, and How Should CEOs React?"

Bullpen is an invite-only Club that gathers Life Science Investors and Senior Executives with a shared goal of helping each other.

Bullpen Pitch Fest - Minneapolis, MN

Aug 14, 2024

Christiaan Engstrom, CEO, Bullpen

Bullpen is an invite-only Club that gathers Life Science Investors and Senior Executives with a shared goal of helping each other.

Panel on Strategic Investors

Project Medtech Midwest Showcase - Chicago, IL

May 8, 2024

Ross Meisner, CCO, Basil Systems

Panel on Strategic Investors

Panel on Enabling Success: A Discussion of the New Technologies Transforming Orthopedics

Orthopedic Design & Technology Forum - Memphis, TN

Apr 24, 2024

Dave Sheppard, Co-Founder, Medworld Advisors

Panel on Enabling Success: A Discussion of the New Technologies Transforming Orthopedics

Judge for the MedTech Industry's Leading Accelerator

Medtech Innovator East Coast Pitch Event - Washington, DC

Apr 2, 2024

Paul Grand, CEO, Medtech Innovator

Judge for the MedTech Industry's Leading Accelerator

Haynes Boone Investor Panel, Cancer Therapeutics

JP Morgan Healthcare Conference - San Francisco, CA

Jan 10, 2024

Roger Royse, Corporate and Tax Partner, Haynes and Boone, LLP

Haynes Boone Investor Panel, Cancer Therapeutics

M&A: Getting the Golden Ticket Panel

Project Medtech Startup Symposium - Houston, TX

Oct 30, 2023

Rich Mazzola, CFO & Co-Founder, Project Medtech

M&A: Getting the Golden Ticket Panel

Articles

MadSci Announces $10 Million Oversubscribed Seed Financing to Advance Smart Technology for Neurologic Conditions

Sep 8, 2025

Tyler Wanke

Memphis Solo GP files to raise $10MM, builds-out investment committee and platform.

Heinz Ventures Fund I eyes medtech targets, adds venture partners

Jan 6, 2025

Milt Capps

Memphis Solo GP files to raise $10MM, builds-out investment committee and platform.

Eric shares lessons learned after 3 months fundraising

Lessons From the Frontline: My First Venture Into Fundraising

Jun 25, 2024

Eric Heinz

Eric shares lessons learned after 3 months fundraising

Patent applications offer a unique glimpse into a company's research and development pipeline.

The Innovation Pipeline: How Patents Drive Growth in Orthopedics

May 21, 2024

Eric Heinz

Patent applications offer a unique glimpse into a company's research and development pipeline.

A Career Origin Story

Lessons From Turning Over Room 15

May 9, 2022

Eric Heinz

A Career Origin Story

Reflections on my first year in the Kellogg EMBA Program

Leading with Purpose - Reflecting on Year 1 of the Kellogg EMBA

Nov 16, 2021

Eric Heinz

Reflections on my first year in the Kellogg EMBA Program

LinkedIn Post on The Start of My Kellogg EMBA Journey

COVID 19 - The Catalyst For Self Reflection and Development

Jan 13, 2021

Eric Heinz

LinkedIn Post on The Start of My Kellogg EMBA Journey

Director of business development, M&A, Smith & Nephew Inc.

Memphis Business Journal 40 Under 40

Nov 17, 2019

John Klyce

Director of business development, M&A, Smith & Nephew Inc.

Heinz Ventures Logo
  • LinkedIn

You acknowledge that the content of the site is for general, informational purposes only and is not intended to constitute an offer to sell or buy any securities or other assets or promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.

The contents of the site may contain forward-looking statements that are based on management's beliefs, assumptions, current expectations, estimates, and projections about the medtech industry, the economy, the firm itself or its investments.  These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict with regards to timing, extent, likelihood and degree of occurrence.  Therefore, actual results and outcomes may materially differ from what may be expressed or forecasted in such forward-looking statements.

©2025 by Heinz Ventures, LLC. All Rights Reserved.

Important Legal Information and Terms of Use

Website Privacy Policy

bottom of page